| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain
|
Ivanov, Ivan
|
|
|
133 |
10 |
p. 1152-1163
|
artikel
|
| 2 |
Editorial Board
|
|
|
|
133 |
10 |
p. i
|
artikel
|
| 3 |
Genetic predisposition to MDS: clinical features and clonal evolution
|
Kennedy, Alyssa L.
|
|
|
133 |
10 |
p. 1071-1085
|
artikel
|
| 4 |
Genetics of MDS
|
Ogawa, Seishi
|
|
|
133 |
10 |
p. 1049-1059
|
artikel
|
| 5 |
Genetic susceptibility to breast cancer in lymphoma survivors
|
Allan, James M.
|
|
|
133 |
10 |
p. 1004-1006
|
artikel
|
| 6 |
Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma
|
Opstal-van Winden, Annemieke W.J.
|
|
|
133 |
10 |
p. 1130-1139
|
artikel
|
| 7 |
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients
|
Christen, Friederike
|
|
|
133 |
10 |
p. 1140-1151
|
artikel
|
| 8 |
Heavy chain of FXII: not an innocent bystander!
|
Philippou, Helen
|
|
|
133 |
10 |
p. 1008-1009
|
artikel
|
| 9 |
Introduction to a review series on myelodysplastic syndromes
|
Löwenberg, Bob
|
|
|
133 |
10 |
p. 1001
|
artikel
|
| 10 |
Juvenile myelomonocytic leukemia: who's the driver at the wheel?
|
Niemeyer, Charlotte M.
|
|
|
133 |
10 |
p. 1060-1070
|
artikel
|
| 11 |
Lamotrigine-associated hemophagocytic lymphohistiocytosis
|
Hancock, Christie L.
|
|
|
133 |
10 |
p. 1165
|
artikel
|
| 12 |
MDS overlap disorders and diagnostic boundaries
|
Tanaka, Tiffany N.
|
|
|
133 |
10 |
p. 1086-1095
|
artikel
|
| 13 |
MHC class II cell-autonomously regulates self-renewal and differentiation of normal and malignant B cells
|
Merkenschlager, Julia
|
|
|
133 |
10 |
p. 1108-1118
|
artikel
|
| 14 |
More than a fusion gene: the RUNX1-RUNX1T1 AML
|
Haferlach, Torsten
|
|
|
133 |
10 |
p. 1006-1007
|
artikel
|
| 15 |
Nuclear protrusion in dysplastic micromegakaryocytes
|
Pérez-Ortega, Laura
|
|
|
133 |
10 |
p. 1164
|
artikel
|
| 16 |
Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials
|
Platzbecker, U.
|
|
|
133 |
10 |
p. 1020-1030
|
artikel
|
| 17 |
Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia
|
Burger, Jan A.
|
|
|
133 |
10 |
p. 1011-1019
|
artikel
|
| 18 |
Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints
|
Andor, Noemi
|
|
|
133 |
10 |
p. 1119-1129
|
artikel
|
| 19 |
Targeting CD20 takes the backseat in CLL
|
Byrd, John C.
|
|
|
133 |
10 |
p. 1003-1004
|
artikel
|
| 20 |
The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes
|
Sallman, David A.
|
|
|
133 |
10 |
p. 1039-1048
|
artikel
|
| 21 |
The mesenchymal niche in MDS
|
Pronk, Eline
|
|
|
133 |
10 |
p. 1031-1038
|
artikel
|
| 22 |
Treatment of MDS
|
Platzbecker, Uwe
|
|
|
133 |
10 |
p. 1096-1107
|
artikel
|
Tijdschrift beschrijving